BIBLIOGRAPHIC RECORD

The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents.

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Christoph U Correll; Marco Solmi; Samuele Cortese; Maurizio Fava; Mikkel Højlund; Helena C Kraemer; Roger S McIntyre; Daniel S Pine; Lon S Schneider; John M Kane
Source of metadata
PubMed
Year recorded
2023

Public identifiers and source

Open the source record

Reference

Christoph U Correll; Marco Solmi; Samuele Cortese; Maurizio Fava; Mikkel Højlund; Helena C Kraemer; Roger S McIntyre; Daniel S Pine; Lon S Schneider; John M Kane. (2023). The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents. https://pubmed.ncbi.nlm.nih.gov/36640403/

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-b6493ab247e5dc291448fcfaddceef92/